Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 1
Panelists discuss how graft-vs-host disease (GVHD) is a complex immune-mediated condition, highlighting the differences between acute and chronic GVHD, the associated risk factors, prognosis, and the impact of increased cyclophosphamide use on the clinical presentation of the disease.
Video content above is prompted by the following: